Detection and characterization of a pancreatic tumor inhibitory factor

D A Colacchio1, M H Goldrosen

  • 1Department of Surgical Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263.

Insights

Researchers discovered a tumor growth inhibitory factor (TIF) produced by human pancreatic cancer cells. This TIF regulates cellular proliferation and shows potential for cancer research.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Growth factors stimulating cellular proliferation are well-documented.
  • Limited knowledge exists regarding autocrine factors that inhibit tumor growth.

Purpose of the Study:

  • To investigate if the human pancreatic cancer cell line RWP-1 produces a tumor growth inhibitory factor (TIF).

Main Methods:

  • RWP-1 serum-free conditioned media (CM) was concentrated.
  • The effect of CM on DNA synthesis was measured via [3H]thymidine incorporation.
  • Characterization of TIF properties including stability and molecular weight.

Main Results:

  • Concentrated CM inhibited [3H]thymidine incorporation in a dose-dependent and non-toxic manner across tested cell lines.
  • The TIF demonstrated stability at 56°C but was labile at 95°C.
  • TIF activity was partially inactivated by acid, reduction/alkylation, and enzymatic digestion, suggesting a polypeptide nature (>5000 Da).
  • The TIF showed differential activity against various cell lines, including a normal murine fibroblast line.

Conclusions:

  • The RWP-1 cell line produces a TIF that regulates cellular proliferation.
  • The TIF is a polypeptide with a molecular weight greater than 5000 Da.
  • Further research is needed for TIF isolation due to potential involvement of multiple factors.

Related Concept Videos